Chesnara Plc: Fourth acquisition in two years
12 November 2026
Fulgent Genetics, Inc. (NASDAQ: FLGT) stands at an intriguing junction, presenting both challenges and opportunities for investors. With a market capitalization of $458.47 million, this healthcare..
For investors eyeing opportunities in the biotechnology sector, Prothena Corporation plc (NASDAQ: PRTA) presents an intriguing case. With a market capitalization of $501.19 million, this Ireland-based..
Zenas BioPharma, Inc. (ZBIO), a clinical-stage biopharmaceutical innovator, stands out in the biotechnology sector with its impressive potential upside of 66.33%, as noted by analysts. With..
AtaiBeckley Inc. (ATAI), a burgeoning player in the biotechnology sector, is capturing investor attention with its innovative approach to mental health treatments. Despite recent price volatility,..
Investors with an eye on the biotechnology sector may find Oculis Holding AG (NASDAQ: OCS) an intriguing prospect, given its compelling growth potential and strategic focus..
Nurix Therapeutics, Inc. (NASDAQ: NRIX) is capturing the attention of investors with its promising potential upside, backed by a robust pipeline and strategic partnerships. As a..
Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, is attracting attention with its focus on developing targeted therapies for solid tumors. With a market capitalization of..
Verastem, Inc. (VSTM), a biopharmaceutical company with a focus on oncology, presents a compelling opportunity for investors with its ambitious drug development pipeline and robust analyst..
Cullinan Therapeutics, Inc. (NASDAQ: CGEM) has emerged as a noteworthy player in the biotechnology sector, attracting attention with its promising clinical-stage developments and an eye-catching potential..
Cel-Sci Corporation (NASDAQ: CVM) has captured the attention of investors with its staggering potential upside of 610.23%, according to analyst ratings. As a clinical-stage biotechnology company,..
For investors with an eye on the biotechnology sector, Savara, Inc. (NASDAQ: SVRA) presents an intriguing opportunity. This clinical-stage biopharmaceutical company, headquartered in Langhorne, Pennsylvania, is..
LifeMD, Inc. (LFMD), a prominent player in the healthcare sector with a focus on health information services, is drawing significant attention from analysts and investors alike...
For investors scouring the healthcare sector for potential high-return opportunities, Organogenesis Holdings Inc. (NASDAQ: ORGO) might just be the ticket. With a market capitalization of $340.9..
Beta Bionics, Inc. (NASDAQ: BBNX) is capturing investor attention with a staggering potential upside of 131.62%, as revealed by recent analyst ratings. Specializing in the healthcare..
Myriad Genetics, Inc. (NASDAQ: MYGN), a key player in the healthcare sector’s diagnostics and research industry, is drawing attention from investors with its potential upside of..
Arvinas, Inc. (NASDAQ: ARVN) is a clinical-stage biotechnology company making waves in the healthcare sector with its groundbreaking approach to drug development. Specializing in the discovery,..
Sonida Senior Living, Inc. (NASDAQ: SNDA) operates within the healthcare sector, focusing on a critical demographic—senior citizens. With a market capitalization of $630.85 million, Sonida presents..
Fortrea Holdings Inc. (FTRE), a burgeoning entity in the biotechnology industry, has emerged as a notable player within the healthcare sector. Headquartered in Durham, North Carolina,..
Relay Therapeutics, Inc. (NASDAQ: RLAY), a clinical-stage precision medicines company, is garnering significant attention from investors due to its notable potential upside of 48.21% based on..
Delcath Systems, Inc. (NASDAQ: DCTH) offers a promising investment opportunity within the healthcare sector, specifically in the medical devices industry. The company, headquartered in Queensbury, New..
